About Us

We believe our passion can lead to real change for patients, and our approach goes beyond what’s expected

Committed to improving the lives of patients suffering from acid-related gastrointestinal disorders.

Phathom Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing new treatments for gastrointestinal (GI) disorders. We have licensed the exclusive rights in the United States, Europe, and Canada for an investigational potassium-competitive acid blocker (PCAB) which the company is developing for the treatment of certain GI disorders.

We completed two Phase 3 clinical trials for the treatment of H. pylori infection and erosive GERD and are currently running a Phase 3 trial studying daily dosing therapy for patients with non-erosive reflux disease (NERD).

Management Team

Meet our team of experts working to usher in a new era of treatment for patients with acid-related disorders.

terrie curran

Terrie Curran

President & Chief Executive Officer

azmi nabulsi

Azmi Nabulsi, M.D., M.P.H.

Chief Operating Officer

phathom edit headshot5 010320 v01

Martin Gilligan

Chief Commercial Officer

joe hand

Joe Hand, J.D.

Chief Administrative Officer

tom harris

Tom Harris

Chief Development Sciences Officer

phathom edit headshot5 010320 v01

Molly Henderson

Chief Financial & Business Officer

eckhard leifke

Eckhard Leifke, M.D., Ph.D.

Chief Medical Officer

larry miller

Larry Miller, J.D.

General Counsel

Board of Directors

Terrie Curran

Terrie Curran

President & Chief Executive Officer, Phathom

David Socks

David Socks

Chief Financial Officer & Chief Business Officer, HilleVax, Inc.

michaelcola newbg

Michael Cola

Former Chief Executive Officer, Avalo Therapeutics, Inc.

Frank headshot 01

Frank Karbe

President & Chief Executive Officer, Better Therapeutics, Inc.

Heidi Kunz

Heidi Kunz

Former Chief Financial Officer, Blue Shield California

Asit Parikh

Asit Parikh, M.D., Ph.D.

President & Chief Executive Officer, MOMA Therapeutics

david socks

Mark Stenhouse

Chief Operating Officer, Prometheus Biosciences

jamietopper327x327 1

James Topper, M.D., Ph.D.

Managing Partner, Frazier Life Sciences

Phathom Co-Founders

Tachi Yamada

Tadataka (Tachi) Yamada, M.D.

Co-Founder and Late Chairman, Phathom

David Socks

David Socks

Co-Founder, Phathom

azmi nabulsi

Azmi Nabulsi, M.D., M.P.H.

Co-Founder, Phathom

aditya kohli

Aditya Kohli, Ph.D.

Co-Founder, Phathom